Wrona M Z, Yang Z, Zhang F, Dryhurst G
Department of Chemistry and Biochemistry, University of Oklahoma, Norman 73019, USA.
NIDA Res Monogr. 1997;173:146-74.
In the event that methamphetamine evokes HO. formation within serotonergic axon terminals, the resultant oxidation of 5-HT would be expected to generate not only 5,6-DHT but also T-4,5-D, 7-S-Glu-T-4,5-D, 6, 8, and 7,7'-D (figure 1), at least three of which (T-4,5-D, 7-S-Glu-T-4,5-D, and 6) are lethal in mouse brain. Furthermore, several intermediates/products formed in the in vitro oxidation of 5-HT by HO. are readily autoxidized (4,5-DHT, 5,6-DHT, 5, 7, and 9) or redox cycled (T-4,5-D, 6, 8, 7,7'-D, 7-S-Glu-T-4,5-D) in reactions that would be expected to yield O2-. and/or H2O2 as byproducts. These byproducts, in the presence of trace levels of transition metal ion catalysts, would be readily converted into HO. (Walling 1975; Halliwell and Gutteridge 1984). Together these putative aberrant oxidative metabolites of 5-HT and HO.-forming reactions might contribute to the degeneration of serotonergic nerve terminals. Similarly, the methamphetamine-induced intraneuronal formation of HO. in dopaminergic terminals might be expected to generate not only 6-OHDA (and 2-OHDA and 5-OHDA, figure 3) but also 5,-S-CyS-DA and 5-S-Glu-DA, precursors of DHBT 17 and other more complex dihydrobenzothiazines (figure 4). DHBTs 17 to 19 are lethal in mouse brain, although at this time the biochemical/chemical mechanisms underlying this toxicity and specific neuronal systems affected are unknown. However, 5-S-CyS-DA and 17 to 19 are much more easily oxidized than DA, and the latter DHBTs appear to be capable of redox cycling reactions (Zhang and Dryhurst 1994). Thus, the HO.-mediated oxidation of DA in dopaminergic nerve terminals induced by methamphetamine might be expected to generate aberrant oxidative metabolites that (as a result of autoxidation and redox cycling reactions) potentiate formation of O2-. and/or H2O2, and then HO. and neuronal damage. A number of lines of evidence, discussed previously, suggest that aberrant metabolite(s) of DA (other than or in addition to 6-OHDA) might contribute to the methamphetamine-induced degeneration of not only dopaminergic terminals but also serotonergic terminals. Similarly, aberrant metabolite(s) of 5-HT (other than or in addition to 5,6-DHT) might be involved in the degeneration of serotonergic and dopaminergic terminals and a subpopulation of cell bodies in the somatosensory cortex. Experimental evidence indicates that some of the neurodegenerative effects evoked by methamphetamine are mediated by NMDA and GABA receptors. Thus, it will be of considerable interest to investigate the neurotoxicity of putative aberrant oxidative metabolites of 5-HT (figures 1 and 2) and DA (figures 4 and 5) towards serotonergic, dopaminergic, and other neuronal systems and their interactions with NMDA, GABA, and other brain receptors. A central question relates to mechanisms by which methamphetamine might evoke the intraneuronal formation of oxygen radicals that appear to play important roles in the overall neurodegenerative processes evoked by this drug (DeVito and Wagner 1989; Cadet et al. 1994). Once putative oxidative metabolites of 5-HT such as T-4,5-D, 7-S-Glu-T-4,5-D, 5,6-DHT, 6, 8, and 7,7'-D (figure 1) are formed intraneuronally, autoxidation/redox cycling reactions should, in principle, be capable of generating O2-. and/or H2O2, the precursors of HO.. Similarly, intraneuronal formation of 6-OHDA, 5-S-CyS-DA, and DHBTs 17 to 19 and 22 would also be expected to potentiate elevated fluxes of O2-., H2O2, and HO. as a result of the facile autoxidation/redox cycling reactions of these putative aberrant metabolites. The presence of very low concentrations of 5-S-CyS-DA in DA-rich regions of human and other mammalian brains suggest that autoxidation (Rosengren et al. 1985; Fornstedt et al. 1986, 1989, 1990) or perhaps some other form of DA oxidation is a normal reaction in vivo. Furthermore, available evidence suggests that it is cytoplasmic DA that is oxidized to give 5-S-CyS-DA (Fornstedt et al. 1989; Fornstedt and
如果甲基苯丙胺在5-羟色胺能轴突终末引发羟基自由基(HO·)的形成,那么5-羟色胺(5-HT)的氧化不仅会生成5,6-二羟色胺(5,6-DHT),还会生成T-4,5-D、7-S-谷胱甘肽-T-4,5-D、6、8以及7,7'-D(图1),其中至少有三种(T-4,5-D、7-S-谷胱甘肽-T-4,5-D和6)在小鼠脑内具有致死性。此外,HO·介导的5-HT体外氧化过程中形成的几种中间体/产物很容易发生自氧化(4,5-DHT、5,6-DHT、5、7和9)或氧化还原循环(T-4,5-D、6、8、7,7'-D、7-S-谷胱甘肽-T-4,5-D),这些反应预计会产生副产物超氧阴离子(O2-)和/或过氧化氢(H2O2)。在痕量过渡金属离子催化剂存在的情况下,这些副产物会很容易转化为HO·(沃林,1975;哈利威尔和古特里奇,1984)。这些推测的5-HT异常氧化代谢产物和HO·形成反应可能共同导致5-羟色胺能神经终末的退化。同样,甲基苯丙胺诱导的多巴胺能终末内神经元内HO·的形成可能不仅会生成6-羟基多巴胺(6-OHDA,以及2-OHDA和5-OHDA,图3),还会生成5,-S-半胱氨酸-多巴胺(5,-S-CyS-DA)和5-S-谷胱甘肽-多巴胺(5-S-Glu-DA),它们是二氢苯并噻嗪17(DHBT 17)和其他更复杂的二氢苯并噻嗪的前体(图4)。DHBTs 17至19在小鼠脑内具有致死性,尽管目前这种毒性的生化/化学机制以及受影响的特定神经元系统尚不清楚。然而,5-S-CyS-DA和17至19比多巴胺更容易被氧化,并且后者的二氢苯并噻嗪似乎能够进行氧化还原循环反应(张和德赖赫斯特